Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

Arhalofenate · MBX-102, CB-102

Small molecule · developed by Gilead Sciences

Phase 2 Most advanced trial (none active)

GILD Developer

2 Registered trials

What is Arhalofenate?

Arhalofenate (also known as MBX-102, CB-102 and M-102) is a drug studied in type 2 diabetes mellitus, hyperuricemia and gout.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as: MBX-102, CB-102, M-102
Drug type: Small molecule
Therapy area: Metabolic, Musculoskeletal
Developer: Gilead Sciences (GILD)
FDA status: Investigational, not approved in the US. Most advanced trial: Phase 2
UNII: 1P01UJR9X1

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT01336686	Phase 2	Hyperuricemia	Completed	GILD
NCT00814372	Phase 2	Type 2 Diabetes Mellitus	Terminated	GILD

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

GoutHyperuricemiaType 2 Diabetes Mellitus

More from Gilead Sciences

Axicabtagene Ciloleucel FDA approved Bictegravir FDA approved Brexucabtagene Autoleucel FDA approved Bulevirtide FDA approved Cobicistat FDA approved Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDA approved Emtricitabine And Tenofovir Alafenamide FDA approved Emtricitabine/Tenofovir Disoproxil FDA approved Lenacapavir FDA approved Remdesivir FDA approved Sacituzumab Govitecan FDA approved Seladelpar FDA approved

Sources

Updated Oct 11, 2026. Something wrong or missing? Report it on the GILD page.

Follow GILD, the company behind Arhalofenate

See GILD's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

GILD catalysts and pipeline →

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z